Leave it to the Greeks to provide an epic mythology for interpreting the essence of biotech innovation.
As John Maraganore of Cambridge, MA-based Alnylam Pharmaceuticals puts it, drug development is a voyage of Odysseus that requires wily and ingenious problem-solving and extraordinary seamanship. Put another way by Kleanthis Xanthopoulos of Carlsbad, CA-based Regulus Therapeutics, the quest of biotech innovation boils down to a succinct question: “How do you build business in an environment that has been challenging and is likely to continue to be challenging in the future?”
Original Article: Xconomy Forum: The Biotech Odyssey and Xconomy’s Ode to Innovation and Clean Air | Xconomy
